Radiolabeled Monoclonal Antibody in Treating Patients With Progressive Metastatic Androgen-Independent Adenocarcinoma (Cancer) of the Prostate
Clinical trial NCT00081172 · COMPLETED
Trial details
- NCT number
- NCT00081172
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-01-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.